Company profile
UK company 14212968, incorporated on 4 July 2022.
Home - Orfonyx Bio
Here at Orfonyx Bio, we are harnessing our unique insights and proprietary computational platform to develop an emerging class of genetic medicines that target regulatory elements in untranslated regions of genes.
Company number 14212968
Updated 07 Jul 2026 09:49
Financial period: 1 Aug 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUzMDk5NzI4NGFkaXF6a2N4
Published 07 Jul 2026 14:10
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
A spin-out company has been formed (Orfonyx Bio Ltd) founded by ROBERTS (and others) which aims to commericialise uORF-related findings and generate novel molecular medicines for current unmet clinical needs. This biotech company will serve as an ideal vehicle for licensing novel IP to, and further progressing the pre-clinical/clinical development of novel therapies arising from this grant.
Is currently operating at the Oxford BioEscalator (£5 million seed raise) as of late November 2022
